文献速递生殖医学

接受生育治疗的女性心血管疾病住院情况

Cardiovascular disease hospitalizations among women who undergo fertility treatment.
PubMed 文献 · Reprod Biomed Online · 2024-01-08

这项回顾性队列研究纳入1998至2014年在Monash IVF登记的27262名女性,其中24131名接受生育治疗、3131名未接受,并与维多利亚州住院记录链接。结果显示两组心血管疾病住院风险总体无显著差异(校正RR 0.93,95%CI 0.82至1.05),部分接受治疗亚组风险较低,作者认为可能与社会经济劣势有关。

要点

  • 接受与未接受生育治疗女性心血管疾病住院风险总体无显著差异(校正RR 0.93,95%CI 0.82至1.05)。
  • 每周期平均卵母细胞少于5个的接受治疗女性,心血管疾病住院风险显著低于未治疗女性(校正RR 0.80,95%CI 0.70至0.92)。
  • 居住在IRSD第二五分位区域的接受治疗女性,心血管疾病住院风险低于未治疗女性(年龄校正RR 0.66,95%CI 0.49至0.89)。

核心结论

  • 生育治疗与心血管疾病住院风险增加无关。
  • 部分接受治疗女性亚组风险较低,可能由社会经济劣势解释。

研究设计与样本

  • 回顾性队列研究,纳入1998至2014年在Monash IVF登记的所有女性。
  • 队列与维多利亚州住院数据集链接,该数据集包含澳大利亚维多利亚州所有住院记录。
  • 共27262名女性登记,其中24131名接受生育治疗、3131名未接受。
  • 采用泊松回归计算年龄和IRSD校正的心血管疾病住院相对风险,并按心血管疾病亚型、IRSD五分位、刺激周期数和每周期平均卵母细胞数分层。

主要发现

  • 接受治疗与未治疗女性总体心血管疾病住院风险无显著差异(校正RR 0.93,95%CI 0.82至1.05)。
  • 按心血管疾病亚型分析,接受治疗与未治疗女性住院风险无显著差异。
  • 每周期平均卵母细胞少于5个的接受治疗女性,心血管疾病住院风险显著低于未治疗女性(校正RR 0.80,95%CI 0.70至0.92)。
  • 居住在IRSD第二五分位区域的接受治疗女性,心血管疾病住院风险低于未治疗女性(年龄校正RR 0.66,95%CI 0.49至0.89)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Are women who receive fertility treatment at increased risk of cardiovascular disease (CVD) hospitalization compared with women who do not? DESIGN: A retrospective cohort study of all women registered for fertility treatment at Monash IVF between 1998 and 2014. This cohort was linked to the Victorian Admitted Episodes Dataset, which contains records of all hospital admissions in the Australian state of Victoria. Age- and Index of Relative Socioeconomic Disadvantage (IRSD)-adjusted relative risks of CVD hospitalization for women who did or did not undergo fertility treatment were determined using Poisson regression. Risks were calculated overall by CVD subtype and stratified by area-based social disadvantage using IRSD fifths, number of stimulated cycles and mean oocytes per cycle. RESULTS: Of 27,262 women registered for fertility treatment, 24,131 underwent treatment and 3131 did not. No significant difference was found in risk of CVD hospitalization between treated and untreated women overall (adjusted RR 0.93, 95% 0.82 to 1.05) or by CVD subtype. The admission risk for CVD was significantly lower in treated women who had a mean of fewer than five oocytes per cycle (adjusted RR 0.80, 95% CI 0.70 to 0.92) compared with untreated women. Treated women residing in areas within the second IRSD fifth were less likely to be hospitalized for CVD compared with untreated women (age-adjusted RR 0.66, 95% CI 0.49 to 0.89). CONCLUSIONS: Fertility treatment is not associated with increased risk of CVD hospitalization. Lower risk among some subgroups of treated women may be explained by social disadvantage.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Tomic D, Rombauts L, Da Silva Costa F, et al. Cardiovascular disease hospitalizations among women who undergo fertility treatment. Reprod Biomed Online. 2024. PMID: 38663042. doi:10.1016/j.rbmo.2024.103812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。